The present study offers further substantiation of the effects of SGLT2 on mortality and provides new evidence of its effects on ACS, arrhythmia, UTI, kidney injury, hypoglycemia, sepsis and other indices (40). The gene discussed is SLC5A2; the disease is bacterial urinary tract infection.